The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Heterogeneity of Breast Cancer Associations with Five Susceptibility Loci by Clinical and Pathological Characteristics
Open accessAbstract
A three-stage genome-wide association study recently identified single nucleotide polymorphisms (SNPs) in five loci (fibroblast growth receptor 2 (FGFR2), trinucleotide repeat containing 9 (TNRC9), mitogen-activated protein kinase 3 K1 (MAP3K1), 8q24, and lymphocyte-specific protein 1 (LSP1)) associated with breast cancer risk. We investigated whether the associations between these SNPs and breast cancer risk varied by clinically important tumor characteristics in up to 23,039 invasive breast cancer cases and 26,273 controls from 20 studies. We also evaluated their influence on overall survival in 13,527 cases from 13 studies. All participants were of European or Asian origin. rs2981582 in FGFR2 was more strongly related to ER-positive (per-allele OR (95%CI) = 1.31 (1.27-1.36)) than ER-negative (1.08 (1.03-1.14)) disease (P for heterogeneity = 10(-13)). This SNP was also more strongly related to PR-positive, low grade and node positive tumors (P = 10(-5), 10(-8), 0.013, respectively). The association for rs13281615 in 8q24 was stronger for ER-positive, PR-positive, and low grade tumors (P = 0.001, 0.011 and 10(-4), respectively). The differences in the associations between SNPs in FGFR2 and 8q24 and risk by ER and grade remained significant after permutation adjustment for multiple comparisons and after adjustment for other tumor characteristics. Three SNPs (rs2981582, rs3803662, and rs889312) showed weak but significant associations with ER-negative disease, the strongest association being for rs3803662 in TNRC9 (1.14 (1.09-1.21)). rs13281615 in 8q24 was associated with an improvement in survival after diagnosis (per-allele HR = 0.90 (0.83-0.97). The association was attenuated and non-significant after adjusting for known prognostic factors. Our findings show that common genetic variants influence the pathological subtype of breast cancer and provide further support for the hypothesis that ER-positive and ER-negative disease are biologically distinct. Understanding the etiologic heterogeneity of breast cancer may ultimately result in improvements in prevention, early detection, and treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sørlie, T., Perou, C. M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 10,938
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
Repeated observation of breast tumor subtypes in independent gene expression data sets
Sørlie, T., Tibshirani, R., Parker, J., Hastie, T., Marron, J. S., Nobel, A., Deng, S., Johnsen, H., Pesich, R., Geisler, S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0932692100 · Cited by 5,429
Genome-wide association study identifies novel breast cancer susceptibility loci
Easton, D. F., Pooley, K. A., Dunning, A. M., Pharoah, P. D. P., Thompson, D., Ballinger, D. G., Struewing, J. P., Morrison, J., Field, H., Luben, R., et al. (2007) · Nature · doi:10.1038/nature05887 · Cited by 2,319
Self-citationHunter, D. J., Kraft, P., Jacobs, K. B., Cox, D. G., Yeager, M., Hankinson, S. E., Wacholder, S., Wang, Z., Welch, R., Hutchinson, A., et al. (2007) · Nature Genetics · doi:10.1038/ng2075 · Cited by 1,481
Self-citationGenome-wide association study of prostate cancer identifies a second risk locus at 8q24
Yeager, M., Orr, N., Hayes, R. B., Jacobs, K. B., Kraft, P., Wacholder, S., Minichiello, M. J., Fearnhead, P., Yu, K., Chatterjee, N., et al. (2007) · Nature Genetics · doi:10.1038/ng2022 · Cited by 1,122
Self-citationResampling-Based Multiple Testing.
Booth, J. G., Westfall, P. H., & Young, S. S. (1994) · Journal of the American Statistical Association · doi:10.2307/2291234 · Cited by 906
Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24
Gudmundsson, J., Sulem, P., Manolescu, A., Amundadottir, L. T., Gudbjartsson, D., Helgason, A., Rafnar, T., Bergthorsson, J. T., Agnarsson, B. A., Baker, A., et al. (2007) · Nature Genetics · doi:10.1038/ng1999 · Cited by 864
the CORGI Consortium, Tomlinson, I., Webb, E., Carvajal-Carmona, L., Broderick, P., Kemp, Z., Spain, S., Penegar, S., Chandler, I., Gorman, M., et al. (2007) · Nature Genetics · doi:10.1038/ng2085 · Cited by 808
Stacey, S. N., Manolescu, A., Sulem, P., Rafnar, T., Gudmundsson, J., Gudjonsson, S. A., Masson, G., Jakobsdottir, M., Thorlacius, S., Helgason, A., et al. (2007) · Nature Genetics · doi:10.1038/ng2064 · Cited by 786
Self-citationGenome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24
Zanke, B. W., Greenwood, C. M., Rangrej, J., Kustra, R., Tenesa, A., Farrington, S. M., Prendergast, J., Olschwang, S., Chiang, T., Crowdy, E., et al. (2007) · Nature Genetics · doi:10.1038/ng2089 · Cited by 724
Self-citationMatese, J. C., Sørlie, T., Tibshirani, R., Jeffrey, S. S., Johnsen, H., Brown, P. O., Lønning, P. E., Quist, H., Botstein, D., Eisen, M. B., et al. (2020) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/qpxp-y103 · Cited by 679
Multiple regions within 8q24 independently affect risk for prostate cancer
Haiman, C. A., Patterson, N., Freedman, M. L., Myers, S. R., Pike, M. C., Waliszewska, A., Neubauer, J., Tandon, A., Schirmer, C., McDonald, G. J., et al. (2007) · Nature Genetics · doi:10.1038/ng2015 · Cited by 663 · cited 2×
“Other independent variants in the 8q24 region which does not contain known genes, have been associated with prostate cancer risk [11,13,14]; however, the Table 3.”
BackgroundSelf-citationEtiology of Hormone Receptor–Defined Breast Cancer: A Systematic Review of the Literature
Althuis, M. D., Fergenbaum, J. H., Garcia-Closas, M., Brinton, L. A., Madigan, M. P., & Sherman, M. E. (2004) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.1558.13.10 · Cited by 628
Self-citationGene expression profiling predicts clinical outcome of breast cancer
(2002) · Nature · doi:10.1038/news020128-6 · Cited by 533
Ma, H., Bernstein, L., Pike, M. C., & Ursin, G. (2006) · Breast Cancer Research · doi:10.1186/bcr1525 · Cited by 415
Fibroblast growth factor signaling in tumorigenesis
Grose, R., & Dickson, C. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.01.003 · Cited by 404
A common genetic risk factor for colorectal and prostate cancer
Haiman, C. A., Le Marchand, L., Yamamato, J., Stram, D. O., Sheng, X., Kolonel, L. N., Wu, A. H., Reich, D., & Henderson, B. E. (2007) · Nature Genetics · doi:10.1038/ng2098 · Cited by 365
Self-citationReeves, G. K., Beral, V., Green, J., Gathani, T., & Bull, D. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70911-1 · Cited by 284
Adnane, J., Gaudray, P., Ca, D., Crumley, G., Jaye, M., Schlessinger, J., Jeanteur, P., Birnbaum, D., & Theillet, C. G. (1991) · PubMed · Cited by 240
Expression of fgf and fgf receptor genes in human breast cancer
Penault‐Llorca, F., Bertucci, F., Adélaïde, J., Parc, P., Coulier, F., Jacquemier, J., Birnbaum, D., & Delapeyrière, O. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910610205 · Cited by 226
Allred, D. C., Brown, P., & Medina, D. (2004) · Breast Cancer Research · doi:10.1186/bcr938 · Cited by 213
Luqmani, Y., Graham, M., & Coombes, R. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.256 · Cited by 165
Anderson, W. F., Jatoi, I., & Devesa, S. S. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-004-3777-3 · Cited by 117
Genetic variation in 8q24 associated with risk of colorectal cancer
Gruber, S. B., Moreno, V. R., Rozek, L. S., Rennert, H. S., Lejbkowicz, F., Bonner, J. D., Greenson, J. K., Giordano, T. J., Fearon, E. R., & Rennert, G. (2007) · Cancer Biology & Therapy · doi:10.4161/cbt.6.7.4704 · Cited by 83
Heiskanen, M., Kononen, J., Barlund, M. T., Torhorst, J. K. H., Sauter, G., Kallioniemi, A. H., & Kallioniemi, O. (2001) · Analytical Cellular Pathology · doi:10.1155/2001/981218 · Cited by 58
A Crucial Role for Fibroblast Growth Factor Signaling in Embryonic Mammary Gland Development
Dillon, C., Spencer‐Dene, B., & Dickson, C. (2004) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/b:jomg.0000037163.56461.1e · Cited by 43
Keratinocyte growth factor-induced motility of breast cancer cells
Zang, X. P., & Pento, J. T. (2000) · Clinical & Experimental Metastasis · doi:10.1023/a:1011997317994 · Cited by 42
Hishikawa, Y., Tamaru, N., 江島, 邦., Hayashi, T., & Koji, T. (2004) · Archivum histologicum japonicum · doi:10.1679/aohc.67.455 · Cited by 38
Zhang, Y., Sugimoto, Y., Kulp, S. K., et al. (1998) · Oncology Reports · doi:10.3892/or.5.3.577 · Cited by 19
Cited by
Fibroblast growth factor signalling: from development to cancer
Turner, N., & Grose, R. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2780 · Cited by 2,693
FGFR1 Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast Cancer
Turner, N., Pearson, A., Sharpe, R., Lambros, M., Geyer, F., Lopez-Garcia, M. A., Natrajan, R., Marchio, C., Iorns, E., Mackay, A., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3746 · Cited by 732
Mavaddat, N., Barrowdale, D., Andrulis, I. L., Domchek, S. M., Eccles, D., Nevanlinna, H., Ramus, S. J., Spurdle, A., Robson, M., Sherman, M., et al. (2012) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0775 · Cited by 669
Self-citationp53 polymorphisms: cancer implications
Whibley, C., Pharoah, P. D. P., & Hollstein, M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2584 · Cited by 665
Self-citationThomas, G., Jacobs, K. B., Kraft, P., Yeager, M., Wacholder, S., Cox, D. G., Hankinson, S. E., Hutchinson, A., Wang, Z., Yu, K., et al. (2009) · Nature Genetics · doi:10.1038/ng.353 · Cited by 536
Self-citation
Metadata
- Authors
- Garcia-Closas, M., Hall, P., Nevanlinna, H., Pooley, K., Morrison, J., Richesson, D. A., Bojesen, S. E., Nordestgaard, B. G., Axelsson, C. K., Arias, J. I., Milne, R. L., Ribas, G., González-Neira, A., Benítez, J., Zamora, P., Brauch, H., Justenhoven, C., Hamann, U., Ko, Y.-D., Bruening, T., Haas, S., Dörk, T., Schürmann, P., Hillemanns, P., Bogdanova, N., Bremer, M., Karstens, J. H., Fagerholm, R., Aaltonen, K., Aittomäki, K., von Smitten, K., Blomqvist, C., Mannermaa, A., Uusitupa, M., Eskelinen, M., Tengström, M., Kosma, V.-M., Kataja, V., Chenevix-Trench, G., Spurdle, A. B., Beesley, J., Chen, X., Australian Ovarian Cancer Management Group, The Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer, Devilee, P., van Asperen, C. J., Jacobi, C. E., Tollenaar, R. A. E. M., Huijts, P. E. A., Klijn, J. G. M., Chang-Claude, J., Kropp, S., Slanger, T., Flesch-Janys, D., Mutschelknauss, E., Salazar, R., Wang-Gohrke, S., Couch, F., Goode, E. L., Olson, J. E., Vachon, C., Fredericksen, Z. S., Giles, G. G., Baglietto, L., Severi, G., Hopper, J. L., English, D. R., Southey, M. C., Haiman, C. A., Henderson, B. E., Kolonel, L. N., Le Marchand, L., Stram, D. O., Hunter, D. J., Hankinson, S. E., Cox, D. G., Tamimi, R., Kraft, P., Sherman, M. E., Chanock, S. J., Lissowska, J., Brinton, L. A., Peplonska, B., Klijn, J. G. M., Hooning, M. J., Meijers-Heijboer, H., Collee, J. M., van den Ouweland, A., Uitterlinden, A. G., Liu, J., Lin, L. Y., Yuqing, L., Humphreys, K., Czene, K., Cox, A., Balasubramanian, S. P., Cross, S. S., Reed, M. W. R., Blows, F., Driver, K., Dunning, A., Tyrer, J., Ponder, B. A. J., Sangrajrang, S., Brennan, P., McKay, J., Odefrey, F., Gabrieau, V., Sigurdson, A., Doody, M., Struewing, J. P., Alexander, B., Easton, D. F., & Pharoah, P. D.
- Venue
- PLoS Genetics
- Publisher
- Public Library of Science (PLoS)
- Published
- 2008-04-25
- Volume
- 4
- Issue
- 4
- Pages
- e1000054
- ISSN
- 1553-7390 (ISSN-L)
- 1553-7404
- OpenAlex
- W2123153543
- Cited by
- 378
- References
- 30
- FWCI
- 28.12
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.